ML22220A308
| ML22220A308 | |
| Person / Time | |
|---|---|
| Site: | 03038575 |
| Issue date: | 08/08/2022 |
| From: | Casey Alldredge NRC/RGN-IV/DRSS/mlb |
| To: | Document Control Desk |
| References | |
| License-631679-174880 | |
| Download: ML22220A308 (1) | |
See also: IR 05000350/2006001
Text
NRC FORM 374 PAGE OF1 3PAGES
U.S. NUCLEAR REGULATORY COMMISSION Amendment No. 3
MATERIALS LICENSE
Pursuant to the Atomic Energy Act of 1954 , as amended, the Energy Reorganization Act of 1974 (Public Law 93-438) , and Title 10 , Code of Federal Regulations, Chapter I ,
Parts 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 39 , 40 , 70 and 71 , and in reliance on statements and representations heretofore made by the licensee, a license is hereby issued
authorizing the licensee to receive, acquire , possess , and transfer byproduct, source , and special nuclear material designated below; to use such material for the purpose (s)
and at the place (s) designated below; to deliver or transfer such material to persons authorized to receive it in accordance with the regulations of the applicable Part (s). This
license shall be deemed to contain the conditions specified in Section 183 of the Atomic Energy Act of 1954 , as amended, and is subject to all applicable rules, regulations , and
orders of the Nuclear Regulatory Commission now or hereafter in effect and to any conditions specified below .
Licensee In accordance with letter dated 4. Expiration Date: November 30, 2022
1. PET/CT Center of Alaska April 28, 2022,
5. Docket No.: 030-38575
2. 2841 Debarr Road 3. License No.: 50-35006-01 is Reference No.:
Suite 12 amended in its entirety to read as
Anchorage, AK 99508 follows:
6. 7. 8.Byproduct, source, Chemical and/or physical form Maximum amount that licensee 9. Authorized use
and/or special nuclear may possess at any one time
material under this license
A. For use in uptake, dilution and Any byproduct material A.Any As NeededA.A.
permitted by 10 CFR excretion studies permitted by 10 CFR
35.100 35.100.
B. For use in imaging and localization Any byproduct material B.Any As NeededB.B.
permitted by 10 CFR studies permitted by 10 CFR 35.200.
35.200
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 32OFPAGES
License No.: Docket or Reference No.:50-35006-01
MATERIALS LICENSE 030-38575
SUPPLEMENTARY SHEET Amendment No. 3
CONDITIONS
10. Licensed material shall be used or stored at the licensee's facilities located at 2841 Debarr Road, Suite 12, Anchorage, Alaska, 99508.
11. The Radiation Safety Officer (RSO) for this license is Jason B. Ivey, CNMT.
12. Licensed material shall only be used by, or under the supervision of:
A. Individuals permitted to work as authorized users in accordance with 10 CFR 35.13 and 10 CFR 35.14.
B. The following individuals are authorized users for the material and medical uses as indicated:
Authorized Users Material and Use
Julee K. Holayter, M.D. 35.100; 35.200
Lawrence P. Wood, M.D. 35.100; 35.200
.
13. In addition to the possession limits in Item 8, the licensee shall further restrict the possession of licensed material to quantities below the
minimum limit in 10 CFR 30.35(d) for which decommissioning financial assurance is required.
NRC FORM 374A U.S. NUCLEAR REGULATORY COMMISSION PAGE 33OFPAGES
License No.: Docket or Reference No.:50-35006-01
MATERIALS LICENSE 030-38575
SUPPLEMENTARY SHEET Amendment No. 3
14. Except as specifically provided otherwise in this license, the licensee shall conduct its program in accordance with the statements,
representations, and procedures contained in the documents, including any enclosures, listed below. This license condition applies only to
those statements, representations, and procedures that are required to be submitted in accordance with the regulations. Additionally, this
license condition does not limit the licensee's ability to make changes to the radiation protection program as provided for in 10 CFR 35.26.
The U.S. Nuclear Regulatory Commission's regulations shall govern unless the statements, representations, and procedures in the
licensee's application and correspondence impose on the licensee requirements that are more restrictive than or in addition to the
regulations.
A. Application received September 4, 2012 (ML12264A607)
B. Letter dated October 24, 2012 (ML12307A 211 )
FOR THE U .S. NUCLEAR REGULATORY COMMISSION
Date: August 8, 2022 By:
Region 4